Other

Biomemory Launches DNA Shield, First Commercial Product Built on Its Molecular IT Platform

October 16, 2026 1 min read 1 views
cybersecurity enterprise news
The launch follows the acquisition of catalog's assets and the appointment of Laurent Guengant as CEO earlier this year.

Was this article helpful?

0 found this helpful

Ready to protect your organization?

Get started with Phishlens and run your first phishing simulation today.